News Incyte halts ph3 myelofibrosis study, unmet endpoint Incyte has made it clear that the recommendation to stop the study was not due to safety.
News Nexletol shows CLEAR benefit in cardiovascular outcome trial Will a 13% improvement in MACE over placebo be enough to lift lacklustre sales growth?
News Moderna picks Oxfordshire for UK facility Moderna selects Harwell in Oxfordshire for its new UK facility, next door to the UKHSA.
News FDA said no to trials of Elon Musk’s Neuralink chip; report Regulator has numerous concerns about the implantable device's safety, according to Reuters.
News Lilly adds to non-opioid pain pipeline with Confo deal Deal covers an AT2R inhibitor, a class that has been plagued by safety and efficacy issues.
News 23andMe doses first patient in ph2a anti-tumour monotherapy Additionally, the company will be making investor presentations today and next week.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
